129 related articles for article (PubMed ID: 22015929)
1. Splice variant HE4-V3 expression is associated with favorable prognosis in pulmonary adenocarcinoma.
Tokuishi K; Yamashita S; Ohbo K; Kawahara K
Tumour Biol; 2012 Feb; 33(1):103-9. PubMed ID: 22015929
[TBL] [Abstract][Full Text] [Related]
2. Serum level of HE4 is closely associated with pulmonary adenocarcinoma progression.
Yamashita S; Tokuishi K; Moroga T; Yamamoto S; Ohbo K; Miyahara S; Yoshida Y; Yanagisawa J; Hamatake D; Hiratsuka M; Yoshinaga Y; Shiraishi T; Iwasaki A; Kawahara K
Tumour Biol; 2012 Dec; 33(6):2365-70. PubMed ID: 23001907
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of HE4 expression in pulmonary adenocarcinoma.
Yamashita S; Tokuishi K; Hashimoto T; Moroga T; Kamei M; Ono K; Miyawaki M; Takeno S; Chujo M; Yamamoto S; Kawahara K
Tumour Biol; 2011 Apr; 32(2):265-71. PubMed ID: 20953751
[TBL] [Abstract][Full Text] [Related]
4. Human epididymis protein 4, a novel potential biomarker for diagnostic and prognosis monitoring of lung cancer.
Zhang T; Chu L; Tan W; Ye C; Dong H
Clin Respir J; 2024 May; 18(5):e13774. PubMed ID: 38742362
[TBL] [Abstract][Full Text] [Related]
5. HE4 transcription- and splice variants-specific expression in endometrial cancer and correlation with patient survival.
Jiang SW; Chen H; Dowdy S; Fu A; Attewell J; Kalogera E; Drapkin R; Podratz K; Broaddus R; Li J
Int J Mol Sci; 2013 Nov; 14(11):22655-77. PubMed ID: 24252907
[TBL] [Abstract][Full Text] [Related]
6. Potential for the blood-based biomarkers cytokeratin 19 fragment (CYFRA 21-1) and human epididymal protein 4 (HE4) to detect recurrence during monitoring after surgical resection of adenocarcinoma of the lung.
Muley T; He Y; Rolny V; Wehnl B; Escherich A; Warth A; Stolp C; Schneider MA; Meister M; Herth FJ; Dayyani F
Lung Cancer; 2019 Apr; 130():194-200. PubMed ID: 30885344
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of human epididymis protein 4 in malignant pleural effusion in lung cancer.
Lv M; Wang F; Wang X; Zhang C
Cancer Biomark; 2019; 26(4):523-528. PubMed ID: 31658049
[TBL] [Abstract][Full Text] [Related]
8. [Advances of human epididymis protein 4 in lung cancer].
Ma Q; Wang Q; Zhong D
Zhongguo Fei Ai Za Zhi; 2015 Mar; 18(3):184-6. PubMed ID: 25800577
[TBL] [Abstract][Full Text] [Related]
9. Serum Human Epididymis Secretory Protein 4 (HE4) is a Potential Prognostic Biomarker in Non-Small Cell Lung Cancer.
Mo D; He F
Clin Lab; 2018 Sep; 64(9):1421-1428. PubMed ID: 30274019
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the correlation between the expression of WFDC2 in B cells of lung adenocarcinoma tissue and the survival rate of patients].
Zhang H; Lu J; Yang Y; Wang L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 May; 35(5):425-433. PubMed ID: 31223112
[TBL] [Abstract][Full Text] [Related]
11. The Application Value of Serum HE4 in the Diagnosis of Lung Cancer.
Wang Y; Wang Z; Ding Y; Sun F; Ding X
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2405-2407. PubMed ID: 31450913
[TBL] [Abstract][Full Text] [Related]
12. Human epididymis protein 4 is up-regulated in gastric and pancreatic adenocarcinomas.
O'Neal RL; Nam KT; LaFleur BJ; Barlow B; Nozaki K; Lee HJ; Kim WH; Yang HK; Shi C; Maitra A; Montgomery E; Washington MK; El Rifai W; Drapkin RI; Goldenring JR
Hum Pathol; 2013 May; 44(5):734-42. PubMed ID: 23084584
[TBL] [Abstract][Full Text] [Related]
13. Adipophilin expression in lung adenocarcinoma is associated with apocrine-like features and poor clinical prognosis: an immunohistochemical study of 328 cases.
Fujimoto M; Yoshizawa A; Sumiyoshi S; Sonobe M; Menju T; Hirata M; Momose M; Date H; Haga H
Histopathology; 2017 Jan; 70(2):232-241. PubMed ID: 27467545
[TBL] [Abstract][Full Text] [Related]
14. High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer.
Ohkuma R; Yada E; Ishikawa S; Komura D; Kubota Y; Hamada K; Horiike A; Ishiguro T; Hirasawa Y; Ariizumi H; Shida M; Watanabe M; Onoue R; Ando K; Tsurutani J; Yoshimura K; Sasada T; Aoki T; Murakami M; Norose T; Ohike N; Takimoto M; Kobayashi S; Tsunoda T; Wada S
Int J Oncol; 2021 Jan; 58(1):57-69. PubMed ID: 33367933
[TBL] [Abstract][Full Text] [Related]
15. Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease.
Nishiyama N; Masuo M; Nukui Y; Tateishi T; Kishino M; Tateishi U; Morota K; Ohbo K; Miyazaki Y
Respir Investig; 2021 Jan; 59(1):90-98. PubMed ID: 32919933
[TBL] [Abstract][Full Text] [Related]
16. Serum human epididymis protein 4 is associated with the treatment response of concurrent chemoradiotherapy and prognosis in patients with locally advanced non-small cell lung cancer.
Lan WG; Hao YZ; Xu DH; Wang P; Zhou YL; Ma LB
Clin Transl Oncol; 2016 Apr; 18(4):375-80. PubMed ID: 26329292
[TBL] [Abstract][Full Text] [Related]
17. Expression of HE4 in Endometrial Cancer and Its Clinical Significance.
Li X; Gao Y; Tan M; Zhuang H; Gao J; Hu Z; Wang H; Zhu L; Liu J; Lin B
Biomed Res Int; 2015; 2015():437468. PubMed ID: 26539494
[TBL] [Abstract][Full Text] [Related]
18. Serum HE4: An Independent Prognostic Factor in Non-Small Cell Lung Cancer.
Lamy PJ; Plassot C; Pujol JL
PLoS One; 2015; 10(6):e0128836. PubMed ID: 26030627
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses.
Dewan R; Dewan A; Jindal M; Bhardawaj M
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1103-1108. PubMed ID: 31030480
[TBL] [Abstract][Full Text] [Related]
20. Role of serum HE4 as a prognostic marker in carcinoma of the ovary.
Lakshmanan M; Kumar V; Chaturvedi A; Misra S; Gupta S; Akhtar N; Rajan S; Jain K; Garg S
Indian J Cancer; 2019; 56(3):216-221. PubMed ID: 31389384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
